KELLI MARTIN: Open Payments
NPI 1942787528 · TYLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,996 in 70 payments from 12 companies in 2025. Trend: 2023 $1,216 · 2024 $4,148 · 2025 $1,996
Food & beverage: $1,827Education: $169
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $627 |
| Novo Nordisk Inc | 6 | $318 |
| Janssen Biotech, Inc. | 8 | $273 |
| Ardelyx, Inc. | 8 | $269 |
| Madrigal Pharmaceuticals | 6 | $216 |
| Janssen Scientific Affairs, LLC | 1 | $109 |
| Lilly USA, LLC | 3 | $52 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $49 |
| GENZYME CORPORATION | 1 | $26 |
| Braintree Laboratories, Inc. | 1 | $22 |
Products named: TREMFYA, IBSRELA, Wegovy, CREON, REZDIFFRA, RINVOQ, MAVYRET, SKYRIZI.
Industry payments across TX — which companies pay providers there.
